Ariadne Genomics, Inc. today announced that Institut Curie (Paris, France) has licensed PathwayStudio®, the company’s scalable software solution for the visualization and analysis of biological pathways and gene regulation networks. This software will be used for the investigation of tumoral development, tumor classification and treatment customization at the Institut’s Cancer Research Center.
